Toronto-based Arch Biopartners Inc.'s common shares have been approved for listing on the OTCQB venture market under the ACHFF symbol.
The OTCQB market is mainly for early stage and developing companies.
Arch Biopartners is developing several drug candidates for treating infections and other diseases. The company's common shares will continue to trade on the TSX venture exchange under the ARCH symbol.
